source
- Eli Lilly to acquire AtaiBeckley for $2.8 billion, signaling deeper bet on psychedelicsEli Lilly announced on Thursday that it will acquire psychedelic drug developer AtaiBeckley. The purchase price is set at $2.8 billion paid upfront. The sizable upfront payment highlights Lilly's…
- Amylyx to read out pivotal endocrine drug study results later this quarterAmylyx Pharmaceuticals will read out results later this quarter from a study of a new treatment for a rare endocrine disorder. The drug, avexitide, is being developed to prevent severe, uncontroll…